Does BROLUCIZUMAB-DBLL Cause Visual impairment? 446 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 446 reports of Visual impairment have been filed in association with BROLUCIZUMAB-DBLL. This represents 15.9% of all adverse event reports for BROLUCIZUMAB-DBLL.
446
Reports of Visual impairment with BROLUCIZUMAB-DBLL
15.9%
of all BROLUCIZUMAB-DBLL reports
1
Deaths
28
Hospitalizations
How Dangerous Is Visual impairment From BROLUCIZUMAB-DBLL?
Of the 446 reports, 1 (0.2%) resulted in death, 28 (6.3%) required hospitalization.
Is Visual impairment Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BROLUCIZUMAB-DBLL. However, 446 reports have been filed with the FAERS database.
What Other Side Effects Does BROLUCIZUMAB-DBLL Cause?
Vitreous floaters (479)
Vision blurred (416)
Eye inflammation (387)
Visual acuity reduced (365)
Retinal vasculitis (323)
Uveitis (305)
Vitritis (284)
Eye pain (234)
Vitreous opacities (205)
Anterior chamber cell (199)
What Other Drugs Cause Visual impairment?
INSULIN GLARGINE (5,793)
INSULIN LISPRO (4,654)
ADALIMUMAB (3,770)
DUPILUMAB (3,089)
ETANERCEPT (2,489)
FINGOLIMOD (2,147)
AFLIBERCEPT (1,836)
PREGABALIN (1,714)
METHOTREXATE (1,588)
TOFACITINIB (1,544)
Which BROLUCIZUMAB-DBLL Alternatives Have Lower Visual impairment Risk?
BROLUCIZUMAB-DBLL vs BROMAZEPAM
BROLUCIZUMAB-DBLL vs BROMFENAC
BROLUCIZUMAB-DBLL vs BROMHEXINE
BROLUCIZUMAB-DBLL vs BROMOCRIPTINE
BROLUCIZUMAB-DBLL vs BROTIZOLAM